KOMBINIERTE HBV-THERAPIE
Patent europeic · EP3897672 · En vigur
Inscripziun en il register
- Numer da publicaziun
- EP3897672
- Numer da la dumonda
- EP19842679
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- En vigur
- Scrittira da patent
- Concedì
- Annunzià
- 19-12-2019
- Publitgà
- 27-10-2021
- Concedì
- 09-08-2023
- La protecziun finescha il pli tard
- 18-12-2039
- Proxima taxa annuala scadenta
- 31-12-2026
- Classas IPC
- A61K 31/713 (2006.01)A61P 31/20 (2006.01)A61K 39/42 (2006.01)
- Prioritad
- US 201862782896 P 20.12.2018
- Dumonda PCT
- PCT/US2019/067643 19.12.2019
- Publicaziun PCT
- WO2020/132346 25.06.2020
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 01-01-2026
Midada
Published in Swissreg on 01.01.2026
- 08-01-2025
Midada
Published in Swissreg on 08.01.2025
- 19-06-2024
Midada
Published in Swissreg on 19.06.2024
- 01-01-2024
Midada
Published in Swissreg on 01.01.2024
- 08-11-2023
Represchentant inscrit
- Representative
- Swisspat Riederer Hasler Patentanwälte AG, Kappelestrasse 17, 9492 Eschen, Liechtenstein
Published in Swissreg on 08.11.2023
- 13-09-2023
Owner
- Owner
- VIR Biotechnology, Inc., 499 Illinois Street, Suite 500, San Francisco, CA 94158, USA, Humabs Biomed SA, Via dei Gaggini, 3, 6500 Bellinzona → Humabs Biomed SA, Via dei Gaggini, 3, 6500 Bellinzona, Vir Biotechnology, Inc., 1800 Owens Street, Suite 900, San Francisco, CA 94158, USA
Published in Swissreg on 13.09.2023
- 09-08-2023
Concedì
Published in Swissreg on 09.08.2023
Partidas
Possessur
Inventur
San Francisco, California 94158, US
6500 Bellinzona
San Francisco, California 94158, US
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.